On January 30th, the Federal Trade Commission (FTC) released its 2021 report on sales and marketing expenditures for cigarettes and smokeless tobacco in the United States.
According to a report, the largest cigarette company in the United States sold 190.2 billion cigarettes to national wholesalers and retailers in 2021, a decrease from the 203.7 billion sold in 2020. Mint-flavored cigarettes now hold a market share of 37% among major manufacturers, more than double the 16% market share they held in 1963.
Sales of smokeless tobacco decreased from 126.8 million pounds in 2020 to 122 million pounds in 2021, while revenue increased from $4.82 billion in 2020 to $4.96 billion in 2021. Mint-flavored smokeless tobacco products account for over half of all sales, while fruit-flavored smokeless tobacco products make up 2.7%.
In addition, sales of nicotine lozenges or pouches without tobacco in 2021 amounted to $804.8 million, which is higher than the $422.7 million recorded in 2020.
Note: The smokeless tobacco referred to in the report refers to non-burning or non-inhalable tobacco products, including chewing tobacco, snuff, snus, and dissolvable tobacco products, and does not include electronic cigarettes.
Reference:
The 2021 report on cigarettes by the Federal Trade Commission.
The 2021 report on smokeless tobacco by the Federal Trade Commission.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
